Retraction notice to “Cancer immunotherapy-induced posterior reversible encephalopathy syndrome in an emergency department” [Am J Emerg Med 35 (2016) 663-663] (American Journal of Emergency Medicine (2017) 35(4) (663.e1–663.e2), (S0735675716307860) (10.1016/j.ajem.2016.10.069))

Myint Aung Win, Kyaw Zin Thein, Sai Ching Jim Yeung

Research output: Contribution to journalComment/debatepeer-review

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). < This article has been retracted at the request of the authors. The patient actually had urothelial cancer of the renal pelvis and not renal cell carcinoma as had been reported. The authors did not report that the patient's PRES resolved with glucocorticoid treatment. The oncology team disagreed with the authors’ attribution of the metabolic acidosis to posterior reversible encephalopathy syndrome. >

Original languageEnglish (US)
Pages (from-to)2137
Number of pages1
JournalAmerican Journal of Emergency Medicine
Volume36
Issue number11
DOIs
StatePublished - Nov 2018
Externally publishedYes

ASJC Scopus subject areas

  • Emergency Medicine

Fingerprint

Dive into the research topics of 'Retraction notice to “Cancer immunotherapy-induced posterior reversible encephalopathy syndrome in an emergency department” [Am J Emerg Med 35 (2016) 663-663] (American Journal of Emergency Medicine (2017) 35(4) (663.e1–663.e2), (S0735675716307860) (10.1016/j.ajem.2016.10.069))'. Together they form a unique fingerprint.

Cite this